Charles Schwab Investment Management Inc Merrimack Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
BUY
$12.02 - $13.07 $356,128 - $387,237
29,628 New
29,628 $364,000
Q3 2018

Nov 13, 2018
SELL
$3.91 - $4.66 $115,423 - $137,563
-29,520 Closed
0 $0
Q2 2018

Aug 08, 2018
SELL
$3.86 - $7.61 $92,883 - $183,119
-24,063 Reduced 44.91%
29,520 $145,000
Q1 2018

May 07, 2018
SELL
$6.24 - $9.15 $14,589 - $21,392
-2,338 Reduced 4.18%
53,583 $432,000
Q4 2017

Jan 17, 2018
BUY
$7.99 - $11.87 $16,203 - $24,072
2,028 Added 3.76%
55,921 $574,000
Q3 2017

Nov 13, 2017
BUY
$9.13 - $11.72 $492,043 - $631,625
53,893
53,893 $784,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email